Bragar Eagel & Squire, P.C. Is Investigating CareDx, Medallion, Cortexyme, and Corcept and Encourages Investors to Contact the Firm
01 mai 2022 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, May 01, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against CareDx, Inc. (NASDAQ:...
Bragar Eagel & Squire, P.C. Is Investigating Cortexyme, Corcept, RBB, and Verra and Encourages Investors to Contact the Firm
25 avr. 2022 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, April 25, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Cortexyme, Inc. (NASDAQ:...
Bragar Eagel & Squire, P.C. Is Investigating Cortexyme, SelectQuote, Corcept, and Core Scientific and Encourages Investors to Contact the Firm
20 avr. 2022 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, April 20, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Cortexyme, Inc. (NASDAQ:...
Bragar Eagel & Squire, P.C. Is Investigating CareDx, Medallion, Cortexyme, and SelectQuote and Encourages Investors to Contact the Firm
15 avr. 2022 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, April 15, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against CareDx, Inc. (NASDAQ:...
Bragar Eagel & Squire, P.C. Is Investigating Medallion, Cortexyme, SelectQuote, and Corcept and Encourages Investors to Contact the Firm
10 avr. 2022 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, April 10, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Medallion Financial Corp....
Bragar Eagel & Squire, P.C. Is Investigating Cortexyme, Koppers, RBB, and SelectQuote and Encourages Investors to Contact the Firm
30 mars 2022 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, March 30, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Cortexyme, Inc. (NASDAQ:...
Bragar Eagel & Squire, P.C. Is Investigating Sea, Cortexyme, and RBB and Encourages Investors to Contact the Firm
25 mars 2022 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, March 25, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Sea Limited (NYSE: SE),...
Bragar Eagel & Squire, P.C. Is Investigating Sea, Cortexyme, FAT, and Koppers and Encourages Investors to Contact the Firm
18 mars 2022 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, March 18, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Sea Limited (NYSE: SE),...
Bragar Eagel & Squire, P.C. Is Investigating Cortexyme, FAT Brands, Koppers, and RBB and Encourages Investors to Contact the Firm
14 mars 2022 21h27 HE
|
Bragar Eagel & Squire
NEW YORK, March 14, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Cortexyme, Inc. (NASDAQ:...
Bragar Eagel & Squire, P.C. Is Investigating Sea Limited, Cortexyme, FAT, and Koppers and Encourages Investors to Contact the Firm
09 mars 2022 21h00 HE
|
Bragar Eagel & Squire
NEW YORK, March 09, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Sea Limited (NYSE: SE),...